Full-Time
Network Systems Specialist
Backup Administrator
Posted on 2/21/2026
Roswell Park Comprehensive Cancer Center
1,001-5,000 employees
Comprehensive cancer research and treatment center
Compensation Overview
$91.3k/yr
United States
In Person
On-site role; location is Roswell Park Cell & Virus Building (C&V).
 IT & Security (1) |
|---|
- Master’s degree and the equivalent of two (2) years of full-time experience in computer system hardware, operating systems and software, enterprise networking or computer systems security as it relates to technology used at the organization
- Bachelor’s degree and the equivalent of two (2) years of full-time experience as a Network Technician at Roswell Park Comprehensive Cancer Center; or
- Bachelor’s degree and the equivalent of four (4) of full-time experience in computer system hardware, operating systems and software, enterprise networking or computer systems security as it relates to technology used at the organization
- Associates degree and the equivalent of six (6) years of full‐time experience in computer system hardware, operating systems and software, enterprise networking or computer systems security as it relates to technology used at the organization
- High School Diploma or High School Equivalency Diploma and the equivalent of eight (8) years of full‐time experience in computer system hardware, operating systems and software, enterprise networking or computer systems security as it relates to technology used at the organization
- Administer Veeam and Commvault Enterprise Backup platforms.
- Manages backup schedules to ensure regular and timely data protection.
- Monitors backup jobs for successful completion and addresses any anomalies.
- Verifies the integrity of backup data to ensure reliability during restoration.
- Restores data as needed in response to system failures or user requests.
- Troubleshoots backup failures and implements corrective actions.
- Documents backup procedures and maintains logs for audit and compliance purposes.
- Collaborate with IT teams to ensure backup solutions align with business continuity and disaster recovery plans.
Roswell Park Comprehensive Cancer Center brings together laboratory research, clinical care, and education in a multidisciplinary environment to advance cancer treatment. Researchers and clinicians work side by side to translate laboratory findings into patient therapies and contribute to ongoing trials, with historical breakthroughs in chemotherapy, photodynamic therapy, and PSA testing. It differentiates itself as the world’s first cancer-focused laboratory, operates as a public benefit corporation owned by New York State, and relies on grants and donations through affiliated nonprofits. The center’s goal is to conquer cancer by coordinating research, clinical care, and education to improve patient outcomes and scientific knowledge.
Company Size
1,001-5,000
Company Stage
Grant
Total Funding
$71.1M
Headquarters
Buffalo, New York
Founded
1898
Simplify's Take
What believers are saying
- Launched exclusive CD83 CAR T-cell trial for relapsed AML in 2026.
- Developed PhenopyCell AI tool predicting SCLC chemotherapy response.
- Secured $175.14M DASNY bond for facility upgrades and equipment.
What critics are saying
- NCI comprehensive designation ends after 2025, losing referrals to Cleveland Clinic.
- Low TPS Quality Score of 0.00 triggers CMS cuts, diverting patients to Strong Memorial.
- New York State budget cuts post-DASNY bond force service reductions in 6-12 months.
What makes Roswell Park Comprehensive Cancer Center unique
- World's first cancer research lab founded by Dr. Roswell Park in 1898.
- Pioneered combination chemotherapy, photodynamic therapy, and PSA test.
- Only NCI-designated comprehensive cancer center in Upstate New York.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↑ 0%AI breakthrough at Roswell Park targets one of cancer's deadliest forms. TrialSite Staff | Making Biomedical Research Evidence Accessible to All Mar. 31, 2026, 1:00 p.m. Researchers at Roswell Park Comprehensive Cancer Center, led by thoracic oncologist Prantesh Jain, alongside Anant Madabhushi of Emory University, have developed an artificial intelligence-driven tool that may reshape how clinicians treat extensive-stage small cell lung cancer (SCLC) - one of the most aggressive and lethal cancers. The tool, called PhenopyCell, functions as a computational biomarker, analyzing standard pathology slides to predict whether a patient will respond to platinum-based chemotherapy - before treatment even begins. This is critical in SCLC, where roughly 70% of patients present with advanced disease and survival is often measured in just over a year. Quality journalism costs money to produce. Subscription options start at $5 per month which is less than a Starbucks coffee!
Roswell Park faculty to present at National Comprehensive Cancer Network 2026 Annual Conference. Presentation topics range from breast cancer to SurVaxM cancer immunotherapy to CAR-T clinical trial access. Highlights * Roswell Park is a longtime member of this alliance of leading cancer centers * Breast cancer surgeon Dr. Jessica Young to take part in expert panel * Dr. Andrew Storer to speak on redesigning care delivery Newswise - BUFFALO, N.Y. - Clinical researchers from Roswell Park Comprehensive Cancer Center are among the experts invited to share insights and clinical best practices at the National Comprehensive Cancer Network (NCCN) 2026 Annual Conference March 27-29 in Orlando, Florida. Roswell Park is a longtime member of the NCCN. Among those speaking during the meeting will be Reem Dergham, MD, of the Department of Medicine, who will give an invited talk as part of the "Oral Presentations from Top Poster Presenters" session on Friday, March 27, at 4:15 p.m. ET, detailing findings from an early-stage clinical trial of SurVaxM, an immunotherapy developed at Roswell Park, in patients with neuroendocrine tumors (NETs), and Jessica Young, MD, FACS, one of three expert panelists on the Breast Cancer Case Review session on Sunday, March 29, at 9:15 a.m. ET. Both talks will take place at the Caribe Royale Orlando and will be available online for registered attendees. Andrew Storer, PhD, DNP, RN, NP-C, FAANP, Chief Nursing Officer, will speak at an affiliated NCCN Best Practices Committee event, the Operational Excellence in Cancer Care Program, focused on redesigning care delivery. "I'm honored to join NCCN colleagues to share how we're redesigning care delivery to better support patients and care teams," says Dr. Storer, pictured above. "Advancing more efficient, patient-centered systems is core to our mission at Roswell Park." Other Roswell Park team members presenting new research at the conference: * Vaishali Deenadayalan, MD, with senior author Bailey Gleason Fitzgerald, MD - Impact of Embedded Thoracic Oncology Nurse Coordinators on Goals of Care Documentation * Amy Gallagher, PsyD, MSHCT, with senior author Amy Case, MD, FAAHPM - Changing Environment & Culture at a Comprehensive Cancer Center * Fayaz Khan, MD, co-first author - Endothelial Activation and Stress Index Scores as Predictors of Outcomes After Chimeric Antigen Receptor T-cell (CAR T) Therapy * Shaniza Haniff, MBBS, MPH - Machine Learning Models Predict Depression Among Pancreatic and Head and Neck Cancer Patients * Mohammad Zia, PhD, with senior author Mukund Seshadri, DDS, PhD - nSIGHT: A Research Discovery Platform for Visualization, Integration and Retrospective Analysis of Multimodal Clinical Data * Reem Dergham, MD, with senior author Jasmeet Kaur, MD - Clinical Outcomes of Gastric Outlet Obstruction Among Patients with Pancreatic Cancer Stratified by Sex: A Multicenter Analysis * Zunairah Shah, MD, with senior author Sheheryar Kabraji, MD - Validating an LLM for Detecting Enrollment Disparities in Breast Cancer Trials * Jayasree Krishnan, MD, MSPH, with senior author Kannan Thanikachalam, MD - Comparative Survival in Elderly Colon Cancer Patients Treated with Adjuvant CAPOX/FOLFOX Versus 5-FU/Capecitabine * Rahul Kumar Thakur, MD - Access to CAR-T and CD3-Bispecific T-Cell Engager Clinical Trials in the United States Media contact. Type of article. Section.
Castle Connolly names Roswell Park to 2026 Top hospital list. Thursday, March 5, 2026 - 09:00 am Cancer center ranked top hospital in cancer surgery, lung cancer surgery and colon surgery Highlights * Roswell Park recognized in cancer and general surgery categories * Only center in WNY to receive recognition in cancer surgery category * Process uses data to analyze patient journey before, during and after procedur BUFFALO, N.Y. - Research and information leader Castle Connolly has named Roswell Park Comprehensive Cancer Center to its 2026 Top Hospitals list for the cancer surgery and general surgery specialties, including honors for lung cancer surgery and colon surgery. This recognition is based on the same physician-led research behind their prestigious Top Doctor recognition, combining peer input with comprehensive patient data and performance metrics. The list recognizes 1,663 Top Hospitals for their overall excellence and strong performance in 6 specialties and 19 procedures. Those specialties include cancer surgery, heart & vascular surgery, general surgery, obstetrics & gynecological surgery, orthopedic, and urologic surgery. Roswell Park is the only nationally ranked center for cancer surgery, specifically lung cancer surgery, in Western New York. Castle Connolly also recognized the center for general surgery, noting its colon surgery. Hospitals are selected through a rigorous process that uses data to analyze the patient journey while undergoing care, including pre- and post-procedure. Castle Connolly's performance metrics include mortality rate, complication rate, Patient Safety Indicator (PSI90) and Failure to Rescue (FTR). Castle Connolly also factors in the number of Top Doctors within the specialty area for the measured procedure. They incorporate physician expertise through hospital nominations. "This honor underscores our commitment to delivering outstanding cancer care close to home for the people of Western New York and beyond," says Candace S. Johnson, PhD, President & CEO of Roswell Park. "Every member of the Roswell Park team plays a role in earning recognitions like this, and we are grateful for the opportunity to serve our patients with excellence." Earlier this year, Castle Connolly named more than 30 Roswell Park physicians to its Top Doctors list. They represent the top 7% of doctors nationwide. From the world's first chemotherapy research to the PSA prostate cancer biomarker, Roswell Park Comprehensive Cancer Center generates innovations that shape how cancer is detected, treated and prevented worldwide. The Roswell Park team of 4,000+ makes compassionate, patient-centered cancer care and services accessible across New York State and beyond. Rated "Exceptional" by the National Cancer Institute, Roswell Park, founded in 1898, was one of the first NCI-designated comprehensive cancer centers in the country and remains the only one in Upstate New York. To learn more about Roswell Park Comprehensive Cancer Center and the Roswell Park Care Network, visit www.roswellpark.org, call 1-800-ROSWELL (1-800-767-9355) or email [email protected]. Media Contact
Roswell Park unveils new mobile prostate and breast cancer screening unit in Western New York. BUFFALO, N.Y. (WKBW) - Roswell Park Comprehensive Cancer Center has unveiled the new EDDY Mobile Breast & Prostate Cancer Screening Center. The new mobile cancer screening program marks the first in the region to address early detection for the three most common invasive cancers. The unit is funded in part by Governor Hochul and New York State to improve health equity and reduce cancer's burden on underserved urban, rural and minority communities. EDDY will provide convenient access to state-of-the-art screening services for individuals at a higher risk who may have no other options to receive cancer screening services. "We're bringing state-of-the-art screening and expertise to neighborhoods and communities that have been endangered by insufficient resources and barriers to care," Roswell Park CEO Candace Johnson said. "Where you live should not determine how healthy you are." The mobile center will take off in December, with a focus on the City of Buffalo and Niagara Falls. WATCH: Roswell Park unveils new mobile prostate and breast cancer screening unit in Western New York. Data shows that 1 in 8 women will develop breast cancer during their lifetime. Black women who are diagnosed are more likely to have advanced disease and lower survival than white women. Screening can detect a possible cancer before it spreads. Women who are ages 40 and older should be screened yearly, and women should begin speaking with their doctor about it at age 25. "Mammograms save lives, but too many women still miss screenings because of circumstances beyond their control," Roswell Park Chair of Diagnostic and Interventional Imaging Ermelinda Bonaccio said. Since Roswell Park launched Early Detection Driven to You in 2022, the EDDY Mobile Lung Cancer Screening Center has visited 52 unique locations across Western New York, screening nearly 2,000 people. To follow EDDY in the community, learn more about available screening services and watch a virtual tour of the EDDY Mobile Breast & Prostate Cancer Screening Center, go to RoswellPark.org/EDDY. This story was reported on-air by a journalist and has been converted to this platform with the assistance of AI. Its editorial team verifies all reporting on all platforms for fairness and accuracy. A voice for everyone. Wkbw Abc want to hear what's going on in your community. Share your voice and hear from your neighbors.
Newswise - BUFFALO, N.Y. - Roswell Park Comprehensive Cancer Center is proud to welcome Loriana Hernández-Aldama as the keynote speaker at its Second Annual Pro Perspectives Speaker Symposium.